Cotinga Pharmaceuticals Inc (COTQF)
0.0001
0.00 (0.00%)
USD |
OTCM |
Jun 24, 16:00
Cotinga Pharmaceuticals Net Income (Quarterly): -0.4055M for Jan. 31, 2020
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2020 | -0.4055M |
| October 31, 2019 | -0.4054M |
| July 31, 2019 | -0.3966M |
| April 30, 2019 | -0.7067M |
| January 31, 2019 | -0.21M |
| October 31, 2018 | -0.3794M |
| July 31, 2018 | -0.7524M |
| April 30, 2018 | -1.240M |
| January 31, 2018 | -1.011M |
| October 31, 2017 | -1.424M |
| July 31, 2017 | -0.1831M |
| April 30, 2017 | -1.434M |
| January 31, 2017 | -0.9285M |
| October 31, 2016 | -0.571M |
| July 31, 2016 | -1.787M |
| April 30, 2016 | -1.777M |
| January 31, 2016 | -0.4644M |
| October 31, 2015 | -0.7132M |
| July 31, 2015 | -0.7899M |
| April 30, 2015 | -0.7577M |
| January 31, 2015 | -0.8154M |
| October 31, 2014 | -0.8563M |
| July 31, 2014 | -0.8977M |
| April 30, 2014 | -1.109M |
| January 31, 2014 | -0.6282M |
| Date | Value |
|---|---|
| October 31, 2013 | -0.5765M |
| July 31, 2013 | -0.4848M |
| April 30, 2013 | -0.4361M |
| January 31, 2013 | -0.7017M |
| October 31, 2012 | -0.7732M |
| July 31, 2012 | -0.7101M |
| April 30, 2012 | -0.6844M |
| January 31, 2012 | -0.6066M |
| October 31, 2011 | -0.6475M |
| July 31, 2011 | -0.6639M |
| April 30, 2011 | -0.4856M |
| January 31, 2011 | -0.6312M |
| October 31, 2010 | -0.3243M |
| July 31, 2010 | -0.5363M |
| April 30, 2010 | -0.8091M |
| January 31, 2010 | -0.734M |
| October 31, 2009 | -0.9091M |
| July 31, 2009 | -0.8645M |
| April 30, 2009 | -1.076M |
| January 31, 2009 | -0.8137M |
| October 31, 2008 | -0.6623M |
| July 31, 2008 | -0.8502M |
| April 30, 2008 | -0.6092M |
| January 31, 2008 | -0.2711M |
| October 31, 2007 | -0.5112M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-0.4055M
Minimum
Jan 2020
-0.3966M
Maximum
Jul 2019
-0.4025M
Average
-0.4054M
Median
Oct 2019
Net Income (Quarterly) Benchmarks
| Bionoid Pharma Inc | -- |
| Acasti Pharma Inc | -3.166M |
| Aurinia Pharmaceuticals Inc | -26.88M |
| Edesa Biotech Inc | -1.861M |
| Lexaria Bioscience Corp | -0.6495M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 0.3578M |
| EPS Diluted (Quarterly) | -0.0152 |